Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$RXRX stock is up 10% today. Here's what we see in our data.

None

$RXRX stock has now risen 10% today, according to our price data from Polygon. There has been approximately $68,369,662 of trading volume.

It has been the 50th most-searched ticker on Quiver Quantitative over the last day, out of 11,919 total tickers searched.

Here is what we see in our data on $RXRX (you can track the company live on Quiver's $RXRX stock page):

$RXRX Insider Trading Activity

RXRX Insider Trades

$RXRX insiders have traded $RXRX stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

  • BLAKE BORGESON has made 0 purchases and 6 sales selling 330,000 shares for an estimated $1,153,200.
  • CHRISTOPHER GIBSON has made 0 purchases and 6 sales selling 240,000 shares for an estimated $804,800.
  • NAJAT KHAN (CEO and President) has made 0 purchases and 2 sales selling 51,886 shares for an estimated $179,118.
  • BEN R TAYLOR (Chief Financial Officer) has made 0 purchases and 2 sales selling 21,382 shares for an estimated $68,322.
  • NAMANDJE BUMPUS has made 0 purchases and 2 sales selling 8,349 shares for an estimated $28,128.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RXRX Hedge Fund Activity

We have seen 178 institutional investors add shares of $RXRX stock to their portfolio, and 172 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RXRX Revenue

RXRX Quarterly Revenue

$RXRX had revenues of $7.7M in Q2 2026. This is a decrease of -60.1% from the same period in the prior year.

You can track RXRX financials on Quiver Quantitative's RXRX stock page.

You can access data on RXRX stock through the Quiver Quantitative API.

$RXRX Price Targets

Multiple analysts have issued price targets for $RXRX recently. We have seen 4 analysts offer price targets for $RXRX in the last 6 months, with a median target of $7.0.

Here are some recent targets:

  • Vikram Purohit from Morgan Stanley set a target price of $5.5 on 05/14/2026
  • Gil Blum from Needham set a target price of $8.0 on 05/07/2026
  • Priyanka Grover from JP Morgan set a target price of $10.0 on 04/30/2026
  • Michael Ryskin from B of A Securities set a target price of $6.0 on 02/26/2026

You can track data on $RXRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles